Takizawa Shunya, Mitamura Hiroto, Ohnuki Yuko, Kawai Kenji, Ohnuki Yoichi, Nagata Eiichiro, Takahashi Wakoh
Department of Neurology, Tokai University Oiso Hospital, Oiso, Japan.
Department of Ophthalmology, Keio University, Tokyo, Japan.
Front Neurol. 2022 Sep 13;13:953787. doi: 10.3389/fneur.2022.953787. eCollection 2022.
Dentatorubral-pallidoluysian atrophy (DRPLA) is an autosomal dominant neurodegenerative disease with various neurological manifestations. Corneal endothelial degeneration and optic atrophy have been reported separately; however, there are no reports of corneal endothelial degeneration with optic atrophy.
Herein, we present four related patients with DRPLA: two patients (69-year-old woman and 80-year-old man) who exhibited both corneal endothelial degeneration and optic atrophy and another two (49- and 51-year-old women, respectively) who exhibited only corneal endothelial degeneration. We quantified the reduction in corneal endothelial cell density (ECD) and hexagonality using specular microscopy and thinning of the circumpapillary retinal nerve fiber layer (RNFL) using optical coherence tomography (OCT).
This is the first report of DRPLA accompanied by corneal endothelial degeneration and/or optic atrophy, which were both quantified based on the corneal ECD and the circumpapillary RNFL thickness using specular micrography and OCT, respectively. The pathophysiological mechanism is unclear; however, the involvement of the nuclear receptor TLX interacting with atrophin-1 may be implicated in ophthalmic manifestations of DRPLA. Therefore, we recommend performing specular micrography and/or OCT when patients with DRPLA experience visual disturbances.
齿状核红核苍白球路易体萎缩症(DRPLA)是一种常染色体显性神经退行性疾病,具有多种神经学表现。角膜内皮变性和视神经萎缩曾分别有过报道;然而,尚无角膜内皮变性合并视神经萎缩的相关报道。
在此,我们展示了四名患有DRPLA的相关患者:两名患者(一名69岁女性和一名80岁男性)同时出现角膜内皮变性和视神经萎缩,另外两名患者(分别为49岁和51岁女性)仅出现角膜内皮变性。我们使用镜面显微镜对角膜内皮细胞密度(ECD)和六边形化程度的降低进行了量化,并使用光学相干断层扫描(OCT)对视乳头周围视网膜神经纤维层(RNFL)的变薄情况进行了量化。
这是关于DRPLA伴有角膜内皮变性和/或视神经萎缩的首例报道,分别基于角膜ECD和视乳头周围RNFL厚度,利用镜面显微镜检查和OCT对二者进行了量化。其病理生理机制尚不清楚;然而,核受体TLX与萎缩素-1相互作用可能与DRPLA的眼部表现有关。因此,我们建议当DRPLA患者出现视觉障碍时,进行镜面显微镜检查和/或OCT检查。